The Government is to invest £375 million to improve understanding and treatment of neurodegenerative diseases
A £375 million investment is to be provided by the Government over the next 5 years to improve understanding and treatment for a range of neurodegenerative diseases.
The investment will fund projects into a range of diseases such as Pick’s Disease, Frontotemporal dementia, Wernicke-Korsakoff syndrome, Parkinson’s disease dementia, Lewy Body dementia, Alzheimer’s disease, and mild cognitive impairment.
At least £50 million will be made available for research into motor neurone disease (MND) to help find a cure. MND affects 5000 people in the UK; new projects will help researchers better understand the disease and its related conditions.
There is currently only one drug licensed in the UK to treat MND, which slows the progression of the disease and extends someone’s life by a few months. The new investment will accelerate progress across the UK to find better treatments for MND, and give people living with the condition the chance of a better quality of life.
Health and Social Care Secretary, Sajid Javid, said: ‘The UK is a global leader in medical research. Our world-class research sector was central to the discovery of lifesaving treatments for COVID-19 like dexamethasone and tocilizumab, as well as the development of the vaccine programme which has saved hundreds of thousands of lives.
‘We will continue to harness this expertise and innovation to support pioneering projects to find better treatments for those living with motor neurone disease, like the excellent work underway at NIHR Sheffield Biomedical Research Centre where scientists are trialling new drugs to treat the condition.’
Lead image: Kateryna_Kon/stock.adobe.com
Image 1: Kateryna_Kon/stock.adobe.com